News

Powering Next-Level Analytics: ProJect Pharmaceutics’s expanded lab welcomes the Orbitrap Exploris 240 LC-MS to elevate formulation science

Meet ProJect Pharmaceutics at CPhI 2025

Today, we proudly celebrate our 15th company anniversary! 🎉

ProJect Pharmaceutics announces a new partnership with Afinum to support the next phase of its growth.

Meet ProJect Pharmaceutics at 16th World ADC London March 2026

Meet ProJect Pharmaceutics at 15th World ADC London 2025

ProJect Pharmaceutics’ announces extension of service offering: In-use stability studies

ProJect Pharmaceutics receives CIR application renewal (Research Tax Credit) for the benefit of its French customers towards 2025

ProJect Pharmaceutics was granted a US patent on a novel liquid formulation of Bendamustine